Incruse Ellipta vs. Spiriva HandiHaler

Reviewed on 10/20/2020

Are Incruse Ellipta and Spiriva HandiHaler the Same Thing?

Incruse Ellipta (umeclidinium) Inhalation Powder and Spiriva HandiHaler (tiotropium bromide) Inhalation Powder are anticholinergic drugs used for prevention and maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Side effects of Incruse Ellipta and Spiriva HandiHaler that are similar include cold symptoms (stuffy nose, sneezing, cough, sore throat), muscle pain, stomach pain or upset, and constipation.

Side effects of Incruse Ellipta that are different from Spiriva HandiHaler include upper respiratory infection, joint pain, tooth pain, bruising or dark areas of skin, chest pain, and fast or irregular heartbeat.

Side effects of Spiriva HandiHaler that are different from Incruse Ellipta include dry mouth, vomiting, and nosebleed.

Both Incruse Ellipta and Spiriva HandiHaler may interact with other anticholinergic drugs.

Spiriva HandiHaler may also interact with belladonna, cimetidine, hyoscyamine, mepenzolate, methantheline, and scopolamine.

What Are Possible Side Effects of Incruse Ellipta?

Common side effects of Incruse Ellipta include:

What Are Possible Side Effects of Spiriva HandiHaler?

Common side effects of Spiriva HandiHaler include:

  • dry mouth,
  • constipation,
  • upset stomach,
  • vomiting,
  • cold symptoms (stuffy nose, sneezing, sore throat),
  • nosebleed, or
  • muscle pain.

Tell your doctor if you have any serious side effects of Spiriva HandiHaler including:

QUESTION

COPD (chronic obstructive pulmonary disease) is the same as adult-onset asthma. See Answer

What Is Incruse Ellipta?

Incruse Ellipta (umeclidinium) Inhalation Powder is an anticholinergic drug used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

What Is Spiriva HandiHaler?

Spiriva HandiHaler (tiotropium bromide) Inhalation Powder is an anticholinergic drug used to prevent bronchospasm (narrowing of the airways in the lungs) in people with bronchitis, emphysema, or COPD (chronic obstructive pulmonary disease).

What Drugs Interact With Incruse Ellipta?

Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Incruse Ellipta should be taken only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

What Drugs Interact With Spiriva HandiHaler?

Spiriva may interact with atropine, belladonna, cimetidine, clidinium, dicyclomine, glycopyrrolate, hyoscyamine, mepenzolate, methantheline, methscopolamine, propantheline, or scopolamine. Tell your doctor all medications you use. During pregnancy, Spiriva should be used only when prescribed. It is unknown if this medication passes into breast milk. Consult your doctor before breastfeeding.

How Should Incruse Ellipta be Taken?

Incruse Ellipta (umeclidinium 62.5 mcg) should be administered as 1 inhalation dose once daily by the orally inhaled route only. Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use.

How Should Spiriva HandiHaler be Taken?

The recommended dose of Spiriva HandiHaler is two inhalations of the powder contents of one Spiriva capsule, once-daily, with the HandiHaler device.

SLIDESHOW

COPD Foods to Boost Your Health - COPD Diet Tips See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
GSK. Incruse Ellipta Product Information.

www.incruse.com/?

Boehringer Ingelheim. Spiriva Product Information.

https://www.spiriva.com/

Health Solutions From Our Sponsors